目的：通过双通道客观视觉质量分析系统Ⅱ(OQAS Ⅱ)评价有晶状体眼后房型人工晶状体(ICL)植入术对高度近视的临床疗效。

方法：选取2017-12/2018-12安徽医科大学第一附属医院收治的高度近视患者26例52眼，所有患者均行ICL植入术。随访获取所有患者术前BCVA以及术前和术后1wk，1、3mo的UCVA、客观散射指数(OSI)、调制传递函数(MTF)、斯特列尔比(SR)和100%、20%及9%的模拟对比度视力(Predicted VA)等一系列参数。

结果：与术前BCVA相比，术后1wk，1、3mo UCVA情况均优于术前且日渐改善(P<0.01)。与术前OSI、MTF、SR和Predicted VA 100%、20%及9%相比，术后1wk，1、3mo情况均好转(P<0.01)。

结论：ICL植入术能够有效地矫正高度近视，提高裸眼视力。通过OQAS Ⅱ分析，ICL植入术后OSI比术前减小，术后的MTF、SR和Predicted VA 100%、20%及9%比术前均有提高，高度近视患者视觉质量得到良好的改善。

METHODS: A total of 26 eyes of 52 patients with high myopia admitted to the First Affiliated Hospital of Anhui Medical University from December 2017 to December 2018 were selected. All patients underwent ICL implantation. Follow-up to obtain the best corrected visual acuity(BCVA)of all patients. And a series of parameters, such as uncorrected visual acuity(UCVA), object scatter index(OSI), modulation transfer function(MTF), Strehl ratio(SR)and Predicted VA of 100%,20% and 9%,were obtained before and 1wk,1 and 3mo after operation.

RESULTS: Compared with preoperative UCVA and BCVA, the 1wk, 1 and 3mo UCVA were better than preoperative and gradually improved, and the differences were statistically significant(P<0.01). Compared with OSI, MTF, SR and Predicted VA 100%, 20% and 9% before operation, the situation improved at 1wk,1 and 3mo after operation, with statistical significance(P<0.01).

CONCLUSION: ICL implantation can effectively correct high myopia and improve UCVA. Through OQAS II analysis, OSI was reduced after ICL implantation. The postoperative MTF, SR and Predicted VA of 100%, 20% and 9% higher than those before surgery. The visual quality of patients with high myopia was improved after ICL implantation.